Virginia Retirement Systems’s Vir Biotechnology VIR Stock Holding History

Virginia Retirement Systems’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40,318	Closed	-$361K	–	1371
2026 Q1	$361K	Buy	40,318 +200	+0.5%	+$1.59K	﹤0.01%	826
2025 Q4	$242K	Sell	40,118 -15,850	-28%	-$94.4K	﹤0.01%	884
2025 Q3	$320K	Sell	55,968 -1,300	-2%	-$6.65K	﹤0.01%	837
2025 Q2	$289K	Sell	57,268 -3,900	-6%	-$20.9K	﹤0.01%	845
2025 Q1	$396K	Buy	+61,168	New	+$544K	﹤0.01%	816
2023 Q3	$533K	Buy	56,900 +17,000	+43%	+$242K	0.01%	678
2023 Q2	$979K	Sell	39,900 -3,200	-7%	-$80.4K	0.01%	555
2023 Q1	$1M	Buy	43,100 +18,600	+76%	+$476K	0.01%	547
2022 Q4	$620K	Buy	24,500 +5,700	+30%	+$140K	0.01%	771
2022 Q3	$362K	Buy	+18,800	New	+$478K	﹤0.01%	893

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Virginia Retirement Systems's VIR Position: Q2 2026 in Review

Virginia Retirement Systems sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 40,318 shares — an estimated $361K sold.

Virginia Retirement Systems first reported a position in VIR in Q3 2022 and held it in 10 quarters. The position peaked at $1M in Q1 2023. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

Virginia Retirement Systems reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
Virginia Retirement Systems sold 40,318 Vir Biotechnology shares in Q2 2026, an estimated $361K.
Virginia Retirement Systems first reported a position in Vir Biotechnology in Q3 2022 and held it in 10 quarters.
Virginia Retirement Systems's Vir Biotechnology position peaked at $1M in Q1 2023.
237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.